Compound 29d, a derivative of nobiletin, has been shown to increase paclitaxel accumulation in lung cancer cells by reducing P-gp activity, thereby enhancing its antitumor activity (Feng et al., 2020). This evidence concerns the gene PGP and lung cancer.